Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04802096
Other study ID # 202012102RINC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2021
Est. completion date September 16, 2022

Study information

Verified date February 2023
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date September 16, 2022
Est. primary completion date September 16, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - age > 20 years old - diagnosed as exacerbation of COPD - maximal inspiratory pressure (MIP) < 80 cmH2O Exclusion Criteria: - any clinical diagnosis that will influence the measurement, including any history of neuromyopathy - angina, acute myocardial infarction in the previous one month - pregnancy - participated in inspiratory muscle training program in the previous three months - any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) < 24, that will disturb the communication and cooperation of the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
inspiratory muscle training
Intensity of inspiratory muscle training will be set at 30% of maximal inspiratory pressure. Subjects in intervention experimental group will perform 15 breaths per set, 6 sets per day on daily basis. The intervention will be last for 8 weeks.
pulmonary rehabilitation
Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.

Locations

Country Name City State
Taiwan School and Graduate Institute of Physical Therapy of National Taiwan University Taipei Zhongzheng Dist

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diaphragm muscle activation The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia). 10 minutes
Primary Sternocleidomastoid muscle activation The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGSCM). 10 minutes
Secondary The mean median frequency of diaphragm and sternocleidomastoid muscle The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigue. 10 minutes
Secondary Functional exercise capacity Six-minute walking test will be performed to evaluate functional exercise capacity. Considering time of test and recovery, it will be expected to take totally 10 minutes.
Secondary Quality of life evaluation St. George's Respiratory Questionnaire and COPD assessment test will be used to evaluate quality of life. 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT03033251 - High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease N/A
Completed NCT03256604 - A Sputum Screening Test to Rule-out Pneumonia at an Early Stage N/A
Terminated NCT03153826 - Determinants of Lower Limb Muscle Atrophy Induced During an Hospitalization for Exacerbation of COPD N/A
Active, not recruiting NCT03432234 - Respiratory Microbiome and COPD Exacerbations (RESMECOPD)
Recruiting NCT05704881 - Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
Recruiting NCT04319705 - Anti-viral Effects of Azithromycin in Patients With Asthma and COPD Phase 4
Completed NCT05779384 - The COPD Attack Study
Recruiting NCT04955080 - REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)
Completed NCT04122547 - Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis Phase 3
Completed NCT02972775 - 15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease
Completed NCT05750810 - Exacerbations and Their Outcomes International (EXACOS International)
Completed NCT05380869 - POCT PCT in Outpatient LRTI N/A